Company Filing History:
Years Active: 2013-2020
Title: The Innovative Contributions of Ming Teng Koh
Introduction
Ming Teng Koh is a prominent inventor based in Baltimore, MD (US), known for his significant contributions to the field of cognitive function and mental health. With a total of 3 patents, his work focuses on developing methods and compositions that address cognitive impairments and psychiatric disorders.
Latest Patents
One of his latest patents is titled "Methods and compositions for improving cognitive function." This invention relates to methods and compositions for treating cognitive impairment associated with central nervous system (CNS) disorders. In particular, it involves the use of inhibitors of synaptic vesicle glycoprotein 2A (SV2A), either alone or in combination with valproate, to treat cognitive impairment in subjects at risk for age-related cognitive decline.
Another notable patent is "Methods and compositions for treating schizophrenia." This invention outlines methods and compositions for treating schizophrenia or bipolar disorder, particularly mania, through the use of a combination of a synaptic vesicle protein 2A (SV2A) inhibitor and an antipsychotic or their pharmaceutically acceptable derivatives. The methods aim to address both positive and negative symptoms, as well as cognitive impairment associated with these disorders.
Career Highlights
Ming Teng Koh is affiliated with The Johns Hopkins University, where he conducts research and develops innovative solutions in the realm of cognitive health. His work has garnered attention for its potential to improve the quality of life for individuals suffering from CNS disorders.
Collaborations
Ming Teng Koh collaborates with esteemed colleagues such as Michela Gallagher and Rebecca Haberman, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Ming Teng Koh's contributions to the field of cognitive function and mental health through his patents reflect his commitment to advancing scientific knowledge and improving patient outcomes. His work continues to inspire future innovations in the treatment of cognitive impairments and psychiatric disorders.